Pixee Medical's Knee+ NexSight Revolutionizes Knee Surgeries with FDA-Approved Augmented Reality Precision

April 22, 2025
Pixee Medical's Knee+ NexSight Revolutionizes Knee Surgeries with FDA-Approved Augmented Reality Precision
  • Pixee Medical has received FDA 510(k) clearance for its innovative product, Knee+ NexSight, which is an augmented reality solution designed specifically for total knee arthroplasty in U.S. ambulatory surgery centers.

  • The technology enables surgeons to position knee implants with high accuracy tailored to each patient's specifications, eliminating the need for expensive preoperative imaging.

  • Built on insights from orthopedic surgeons, Knee+ NexSight has successfully performed over 10,000 procedures globally, demonstrating its effectiveness in enhancing surgical efficiency.

  • Pixee Medical specializes in augmented reality solutions for orthopedic surgery, with its technologies already positively impacting practices in over 20 countries.

  • An optional connectivity module enhances workflow integration by allowing secure data exchange with third-party web solutions, preparing surgical teams for future technological advancements.

  • Additionally, Knee+ NexSight is designed to minimize environmental impact by reducing physical disposables, making it a sustainable option for surgical environments.

  • The first product from Pixee Medical has already demonstrated significant global success, showcasing the potential of augmented reality in improving the precision and efficiency of orthopedic surgeries.

  • Overall, Knee+ NexSight represents a cost-effective solution that meets the evolving demands of the orthopedic surgical landscape.

  • Its full compatibility with existing implant systems and integration into standard surgical procedures facilitates an easy learning curve for users.

  • Knee+ NexSight offers robotic-like precision in a user-friendly format, allowing surgeons to make accurate intraoperative decisions without the complexities or costs associated with traditional robotic systems.

  • This solution is particularly timely as it addresses the needs of the rapidly growing U.S. ambulatory surgical center market, projected to exceed $75 billion by 2030.

  • Knee+ NexSight is compatible with all major total knee implants and is designed to fit various surgical settings, from outpatient centers to hospitals.

Summary based on 2 sources


Get a daily email with more AR/VR stories

More Stories